The Week Ahead: IPOs, Earnings, And FDA Actions Provide Catalysts
Below is a list of notable corporate events for the week beginning January 22. Note, this list is not comprehensive and all dates are subject to change.
Monday
Conferences
North American International Auto Show Jan. 20 thru Jan. 28
Notable Earnings
Haliburton Company (NYSE: HAL) Q4 premarket
TD Ameritrade Holding Corporation (NASDAQ: AMTD) Q1 after hours
Netflix, Inc (NASDAQ: NFLX) Q4 after hours
Steel Dynamics, Inc (NASDAQ: STLD) Q4 after hours
Secondary Offering Lockup Expirations
RBB Bancorp (NASDAQ: RBB)
Tuesday
Economic
World Economic Forum 2018 in Davos, Jan. 23 thru Jan. 26
API U.S. Crude Oil Inventories 4:30 p.m. ET
Sixth round of NAFTA negotiations take place in Montreal, Jan. 23 thru Jan. 28 (watch car manufacturers, railroads e.g. F, GM, FCAU, KSU, UNP)
Conferences
Blockchain Davos Conference
Canaccord Blockchain Investor Day
Notable Earnings
Kimberly-Clark Corporation (NYSE: KMB) Q4 premarket
Verizon Communications Inc (NYSE: VZ) Q4 premarket
Johnson & Johnson (NYSE: JNJ) Q4 premarket
The Procter & Gamble Company (NYSE: PG) Q2 premarket
Capital One Financial Corporation (NYSE: COF) Q4 after hours
United Continental Holdings, Inc (NYSE: snnUAL) Q4 after hours
Secondary Offering Lockup Expiration
Sienna Biopharmaceuticals, Inc (NASDAQ: SNNA)
Investor Events
The Medicines Company (NASDAQ: MDCO) analyst/investor day
United Continental analyst/investor day
Workhorse Group Inc (NASDAQ: WKHS) business update call 4:30 p.m. ET
Wednesday
Notable Earnings
Comcast Corporation (NASDAQ: CMCSA) Q4 premarket
Abbott Laboratories (NYSE: ABT) Q4 premarket
General Electric Company (NYSE: GE) Q4 premarket
W.W. Grainger Inc (NYSE: GWW) Q4 premarket
Whirlpool Corporation (NYSE: WHR) Q4 after hours
Ford Motor Company (NYSE: F) releasing prelim Q4 and FY17 results 4:15 p.m. ET; BZ NOTE: On Jan. 16, Ford shares fell after the company issued a disappointing outlook for its FY17 and FY18 income.
IPOs
Entera Bio (ENTX)
PagSeguro Digital (PAGS)
IPO Quiet Period Expiration
Secondary Offering Lockup Expiration
Investor Events
CTI Biopharma Corp (NASDAQ: CTIC) shareholder meeting
FDA/Biotech
Synergy Pharmaceuticals Inc (NASDAQ: SGYP) sNDA PDUFA date for Trulance (plecanatide) BZ NOTE: Phase 3 data hit primary endpoints in both doses studied
FDA Tobacco Products AdCom Meeting to review Philip Morris International Inc (NYSE: PM) iQOS BZ NOTE: Committee comments could effect other tobacco stocks (e.g. BTI MO, etc.)
Thursday
Notable Earnings
American Airlines Group Inc (NASDAQ: AAL) Q4 premarket
Southwest Airlines Co (NYSE: LUV) Q4 premarket
Union Pacific Corporation (NYSE: UNP) Q4 premarket
Raytheon Company (NYSE: RTN) Q4 premarket
Northrop Grumman Corporation (NYSE: NOC) Q4 premarket
3M Company (NYSE: MMM) Q4 premarket
Biogen Inc (NASDAQ: BIIB) Q4 premarket
Caterpillar Inc (NYSE: CAT) Q4 premarket
Celgene Corporation (NASDAQ: CELG) Q4 premarket
Fiat Chrysler Automobiles (NYSE: FCAU) Q4 premarket
E*TRADE Financial Corporation (NASDAQ: ETFC) Q4 after hours
Intel Corporation (NASDAQ: INTC) Q4 after hours
Intuitive Surgical, Inc (NASDAQ: ISRG) Q4 after hours
Western Digital Corporation (NASDAQ: WDC) Q2 after hours
Starbucks Corporation (NASDAQ: SBUX) Q1 after hours
IPOs
Gates Industrial (GTES)
Menlo Therapeutics (MNLO)
ProLung (LUNG)
Solid Biosciences (SLDB)
Investor Events
Broadsoft, Inc (NASDAQ: BSFT) shareholder meeting
Friday
Economic
Deadline for President Trump to decide on Sec. 201 Solar Tariffs. BZ NOTE: Higher tariffs could be positive for First Solar, Inc (NASDAQ: FSLR) and Canadian Solar Inc (NASDAQ: CSIQ), negative for SunPower Corporation (NASDAQ: SPWR) and SunRun (NASDAQ: RUN).
Notable Earnings
AbbVie Inc (NYSE: ABBV) Q4 premarket
Colgate-Palmolive Company (NYSE: CL) Q4 premarket
Honeywell International Inc (HON) Q4 premarket
IPOs
Adial Pharmaceuticals (ADIL)
ARMO Biosciences (ARMO)
PlayAGS (AGS)
resTORbio (TORC)
FDA/Biotech
Advanced Accelerator Applications (NASDAQ: AAAP) Lutathera PDUFA date
Aradigm Corporation (NASDAQ: ARDM) Linhaliq (pulmaquin) PDUFA date BZ NOTE: At Jan. 11 FDA Adcom meeting, Linhaliq received a negative 3-12 vote against recommending for approval
See more from Benzinga
ICYMI: Crypto Hedge Funds, Blockchain Roundup, A Pair Of Shippers Downgraded
ICYMI: Snap Sinks, Bitcoin Trust Splits, Facebook's Facelift, Intel's 'Processor-Gate'
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.